Overall, the in vitro data suggest that hepatocyte-specific loss of MC1R could directly promote liver fibrosis and apoptosis, but the pathological hallmarks of NAFLD, i.e. apoptosis, inflammation and fibrosis, might also be a consequence of increased TG accumulation in the liver. Here, MC1R is linked to metabolic dysfunction-associated steatotic liver disease.